A cutting-edge genetic test can rapidly detect and identify almost any kind of disease-causing microorganism in the human ...
The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...
23andMe, a popular South San Francisco-based genetic testing company, is laying off 40% of its workers after struggling with ...
Me, the genetics startup that has repeatedly captured the public imagination and then faced nearly fatal business challenges, ...
A new study led by Genomics England and Queen Mary University of London estimates that genetic testing could identify ...
The familial trend, it turned out, was linked to a genetic mutation. That meant Bill might also be at risk for the disease.
In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...
Recent advances in genetic testing technology have transformed personal health care from general guidelines to precise, ...
The move into drug discovery was seen as an acknowledgement that the breakneck growth in the genetic testing market was unlikely to be sustainable in the long term, as by its very nature it is a ...
NEW YORK — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...
In line with the restructuring initiative, 23andMe is looking for strategic opportunities for its pipeline assets, including ...
Scientists investigated how an inherited genetic variation common among East Asians contributes to drug resistance in cancer cells, driving more aggressive cancer growth. The team trialled a precision ...